JP Morgan Maintains Overweight on MetLife, Raises Price Target to $106

Benzinga Newsdesk www.benzinga.com Positive 75.0%

Neg 0% Neu 0% Pos 75%

JP Morgan analyst Pablo Singzon maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $96 to $106.